MedTrace Logo

Assessing Dose Taken in Opioid Use Disordered Patients With an Electrochemical Sensor

NCT05998876 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2023-08-21

No results posted yet for this study

Summary

CARI Health aims to develop a methadone dose taken sensor that provides real-time data on interstitial fluid (ISF) levels that could be used as a methadone adherence monitor for daily doses. Use of such a monitor would allow for the physician, counselor, patient, and family member to remotely verify that a physician prescribed dose has been taken. Such a verification system can allow methadone clinics greater flexibility in the provision of take-home doses and thus retain more patients in the clinic.

Conditions

Interventions

DEVICE

Remote Medication Monitor (RMM) - Prototype

Inserted Microneedle Electrode Array for assaying dermal interstitial fluid.

DRUG

Daily Methadone Dose

patient takes their prescribed daily dose of methadone

Sponsors & Collaborators

  • Cari Health Inc.

    lead OTHER

Principal Investigators

  • Mohammad Bari, MD · Synergy Research Inc.

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2024-05-31
Completion
2024-06-30
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05998876 on ClinicalTrials.gov